Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fass

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Alimentary Pharmacology & Therapeutics|June 9, 2007
Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groupsR Dickman, S Parthasarathy, I B Malagon, et al.
Digestive Diseases and Sciences|October 23, 1997
Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagusR Fass, J M Yalam, L Camargo, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2000
Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre studyR Fass, U Murthy, C W Hayden, et al.
Alimentary Pharmacology & Therapeutics|November 14, 2008
Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studiesD A Drossman, W D Chey, J F Johanson, et al.
Digestive Diseases and Sciences|November 26, 1999
Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activitiesR Fass, R Hell, R E Sampliner, et al.
Journal of Pediatric Surgery|May 1, 1992
Recurrent peripheral arterial occlusion by leukemic cells sedimentation in acute promyelocytic leukemiaR Fass, M Haddad, R Zaizov, et al.
Gastroenterology|December 3, 1998
Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humansR Fass, B Naliboff, L Higa, et al.
Gut|February 15, 2001
Correlation of oesophageal acid exposure with Barrett's oesophagus lengthR Fass, R W Hell, H S Garewal, et al.
Neurogastroenterology and Motility|October 14, 2017
Severity of ineffective esophageal motility is associated with utilization of skeletal muscle relaxant medicationsV Rangan, N S George, F Khan, et al.
Journal of Clinical Psychopharmacology|January 25, 2003
Efficacy of clozapine in the treatment of atypical antipsychotic refractory schizophrenia: a pilot studyRajesh Narendran, Carolyn M Young, Cynthia A Pristach, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Alimentary Pharmacology & Therapeutics|June 9, 2007
Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groupsR Dickman, S Parthasarathy, I B Malagon, et al.
Digestive Diseases and Sciences|October 23, 1997
Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagusR Fass, J M Yalam, L Camargo, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2000
Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre studyR Fass, U Murthy, C W Hayden, et al.
Alimentary Pharmacology & Therapeutics|November 14, 2008
Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studiesD A Drossman, W D Chey, J F Johanson, et al.
Digestive Diseases and Sciences|November 26, 1999
Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activitiesR Fass, R Hell, R E Sampliner, et al.
Journal of Pediatric Surgery|May 1, 1992
Recurrent peripheral arterial occlusion by leukemic cells sedimentation in acute promyelocytic leukemiaR Fass, M Haddad, R Zaizov, et al.
Gastroenterology|December 3, 1998
Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humansR Fass, B Naliboff, L Higa, et al.
Gut|February 15, 2001
Correlation of oesophageal acid exposure with Barrett's oesophagus lengthR Fass, R W Hell, H S Garewal, et al.
Neurogastroenterology and Motility|October 14, 2017
Severity of ineffective esophageal motility is associated with utilization of skeletal muscle relaxant medicationsV Rangan, N S George, F Khan, et al.
Journal of Clinical Psychopharmacology|January 25, 2003
Efficacy of clozapine in the treatment of atypical antipsychotic refractory schizophrenia: a pilot studyRajesh Narendran, Carolyn M Young, Cynthia A Pristach, et al.
Pageof 13